Michelle Doig
InvestorPartner at Omega Funds
Toronto, Ontario
Writes $100K – $5M checks · typically $1.5M
Find your path to Michelle
474 people in our graph share verified history with Michelle — schools, employers, funds. One of them is your warm intro.
Cathy FriedmanunlockedMichelle: together at Morgan Stanley (1996–1998)
×2Michelle: together at Morgan Stanley
×9Michelle: together at Third Rock Ventures
Experience
- Caldera TherapeuticsBoard Membercurrent2026 — presentBoston, Massachusetts, United States
- Artios Pharma LtdBoard Membercurrent2021 — presentGreater London, England, United Kingdom
- Arrakis TherapeuticsBoard Observercurrent2021 — presentWaltham, Massachusetts, United States
- Omega FundsPartner, Head of Corporate Developmentcurrent2016 — present888 Boylston, suite 1111, Boston, MA 02199
- BridgeBio Oncology TherapeuticsBoard Member2024 — 2026San Francisco Bay Area
- Bicara TherapeuticsBoard Observer2024Boston, Massachusetts, United States
- Omega Alpha SPACPresident and Director2020 — 2023
- Nuvation BioBoard Of Directors2019 — 2021New York, NY and San Francisco, CA
- Third Rock VenturesDirector, Corporate Finance2013 — 201629 Newbury Street, Boston MA 02116
- AbingworthPrincipal, Corporate Finance2004 — 2013London, UK
- Lehman BrothersAssociate2001 — 2002
- J.P. MorganAssociate1998 — 2001
- Morgan StanleyAnalyst1996 — 1998
- Student Works Management ProgramDistrict Manager1993 — 1995Greater Toronto Area, Canada
Skills & more
Mergers2Medical Devices1IPO5Restructuring1Biotechnology3Portfolio Management1Corporate Development17Entrepreneurship3Management Consulting1Commercialization2Valuation3Technology Transfer2
+12 more
Capital MarketsFinanceVenture CapitalPrivate EquityDue DiligenceAsset ManagementCompetitive AnalysisAngel InvestingStrategyStrategic PlanningStrategic PartnershipsCorporate FinanceFrom Michelle's professional profile.
Deals · 3
Caldera Therapeutics, Inc.Board seat
via Omega Funds · filed Jan 2026 · $37.5M raise
TheRas, Inc.Board seat
via Omega Funds · filed May 2024 · $200M raise
Nuvation BioBoard seat
via Omega Funds · filed Oct 2020 · $275.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Omega Funds
Alex Delbridge
Senior Associate at Omega Funds
Anne-Mari Paster
General Partner at Omega Funds
Annie Mitsak
Partner at Cure Ventures
Benjamin Youn
Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Claudio Nessi
Managing Director at Omega Funds
Deirdre Cunnane
COO, General Counsel at Omega Funds
Francesco Draetta
Managing Director at Omega Funds
Frequently asked questions
- Who is Michelle Doig?
- Partner at Omega Funds
- Where does Michelle Doig work?
- Michelle Doig is Partner at Omega Funds.
- What check size does Michelle Doig write?
- Michelle Doig typically writes checks of $100K – $5M.
- What boards does Michelle Doig sit on?
- Michelle Doig holds tracked board seats at Caldera Therapeutics, Inc., Nuvation Bio, TheRas, Inc..
- Where did Michelle Doig go to school?
- Michelle Doig studied at Ivey Business School at Western University (HBA, Business Administration).
Same school
Also attended Ivey Business School at Western University349
ØysteinInvestor at InvestinorVivek RamaswamiPartner at Madrona Venture GroupRay SharmaFounding Partner, CEO at Extreme Venture PartnersHa DuongVP Finance & Operations at Luge CapitalJasmine YangVice President at Sapphire VenturesJaye LandowHead of Investor Relations at FJ Labs
+ 343 more
Shared employers
Also worked at Caldera Therapeutics2
Also worked at Arrakis Therapeutics8
Alan WaltsVenture Partner at Advent Life SciencesNeil KubicaTherapeutics at GENERAL INCEPTIONRichard GasterManaging Partner at venBio PartnersNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsJakob LovenPartner at Nextech Invest
+ 2 more
